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Abstract
Background: Primary health care (PHC) professionals play a key role in population screening of colorectal cancer.
The purposes of the study are: to assess knowledge and attitudes among PHC professionals with regard to
colorectal cancer screening, as well as the factors that determine their support for such screening.
Methods: Questionnaire-based survey of PHC physicians and nurses in the Balearic Islands and in a part of the
metropolitan area of Barcelona.
Results: We collected 1,219 questionnaires. About 84% of all professionals believe that screening for colorectal
cancer by fecal occult blood test (FOBT) is effective. Around 68% would recommend to their clients a colorectal
cancer screening program based on FOBT and colonoscopy. About 31% are reluctant or do not know.
Professionals perceive the fear of undergoing a colonoscopy as the main obstacle in getting patients to participate,
and the invasive nature of this test is the main reason behind their resistance to this program. The main barriers to
support the screening program among PHC professionals are lack of knowledge (nurses) and lack of time
(physicians). On multivariate analysis, the factors associated with reluctance to recommend colorectal cancer
screening were: believing that FOBT has poor sensitivity and is complicated; that colonoscopy is an invasive
procedure; that a lack of perceived benefit could discourage client participation; that only a minority of clients
would participate; thinking that clients are fed up with screening tests and being unaware if they should be
offered something to ensure their participation in the programme.
Conclusions: Two in every three PHC professionals would support a population screening program for colorectal
cancer screening. Factors associated with reluctance to recommend it were related with screening tests
characteristics as sensitivity and complexity of FOBT, and also invasive feature of colonoscopy. Other factors were
related with patients’ believes.
Background
Colorectal cancer is an important health problem in
developed countries, both because of its high incidence
and because it is accompanied by high mortality. In
Spain, colorectal cancer ranks first among all cancers in
terms of incidence and second in terms of mortality in
both sexes together. Every year approximately 25,600
new cases are diagnosed [1] and in 2007 13,416 people
died from the disease (INEbase). The annual adjusted
incidence rates of colorectal cancer are under the aver-
age of the 25-member European Union (UE-25) in men,
and especially in women. On the other hand, Spain’s
adjusted mortality rates are higher than the mean for
the UE-25 in men, but lower in women [2].
There is hard evidence that colorectal cancer screen-
ing with fecal occult blood test (FOBT) and a colono-
scopy on cases with positive FOBT, addressed to the
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any medium, provided the original work is properly cited.population aged 50 to 74 years, effectively reduces color-
ectal cancer mortality and incidence [3], and clearly ful-
fills all the criteria of the World Health Organization for
the development of a population screening program [4].
The European Union [5,6], together with the US Pre-
ventive Services Task Force [7] and the Canadian Task
Force on Preventive Health Care [8] have been recom-
mending it for years.
One crucial element for the success of population-
based screening programs is the participation of a large
percentage of the population (more than 50%) [9]. Thus,
before a program of this type is implemented, how to
ensure compliance is always of great concern. Addition-
ally, it has been noted that individuals who refuse to
participate are precisely those at highest risk of develop-
ing colorectal cancer [10].
Despite evidence of its effectiveness, organized popula-
tion screening for colorectal cancer has only been
implemented on a national scale in France, the United
Kingdom, Finland and northen Italy [8,11]. In Spain,
pilot tests have been carried out in certain regions,
including Catalonia [12]. Experience has shown that
PHC physicians play a key role, since people follow
their advice when deciding whether to get screened or
not [13,14]. Nonetheless, according to some studies
PHC physicians have preconceived negative attitudes
towards colon cancer screening programs that rely on
FOBT [15,16]. The main reasons [17-21] are their skep-
ticism regarding its effectiveness; concern over false
positive and false negative results, i.e., the fear of “doing
more harm than good"; doubts about patients’ willing-
ness to be tested in the absence of symptoms; lack of
t i m ea n dt h ea d d e dw o r k l o a dt h a tc o u l dr e s u l tf r o m
their participation in the program. At the same time,
PHC nursing staff can also play an important role in
colorectal cancer screening [22] because nurses usually
devote more time than other professionals to health
education activities [23].
This study is part of a more comprehensive study that
aims to assess the knowledge and attitudes of PHC pro-
fessionals as well as those of their patients with regard
to population-based colorrectal cancer screening. The
main objective of this first phase is to assess the knowl-
edge and attitudes held by PHC physicians and nurses.
Secondly, we want to identify the factors that determine
the support afforded by these professionals to popula-
tion screening for colorectal cancer.
Methods
Design
This is a cross-sectional descriptive multicentre study
based on a survey conducted among adult care physi-
cians and nurses in a primary health care setting in the
Balearic Islands (1,014,405 inhabitants in 2007) and in
the southern metropolitan area of Barcelona (1,275,679
inhabitants in the same year). Since the year 2000, a
pilot program for population colorectal cancer screening
based on FOBT and colonoscopy has been in place in
the southern metropolitan area of Barcelona (115,867
inhabitants).
Study population
In the Balearic Islands, all 1,001 professionals who were
engaged in primary care at the time of the study (491
physicians and 510 nurses) were invited to participate.
For the area of Barcelona, with 1,188 professionals (623
physicians and 565 nurses), a sample size was computed.
The hypothesis was based on the assumption that 50%
of professionals would support a population screening
program. For a confidence level of 95%, and a precision
of 5%, the required sample size was 297 physicians and
2 7 2n u r s e s .T h e s ew e r ed r a w nf r o mac o n v e n i e n c e
sample of health centres, including teaching and non-
teaching centres and urban and rural centres.
Data collection
The research team developed a questionnaire to be self-
administered and based on a literature review [16,22,24].
In March 2008, we performed a pilot study in two
health centres, one urban and the other rural, and col-
lected 31 questionnaires that were then used to modify
the wording or format of some of the questions.
Between the months of April and June 2008, the defini-
tive questionnaire, was completed by the health profes-
sionals in their own health center during one of their
scheduled meetings. We also used some strategies to
capture health professionals who were absent on the day
the session was held.
Variables
We explored the following variables: socio-demographic;
professional; knowledge about colorectal cancer; knowl-
edge about cancer screening; the performance of FOBT;
attitudes towards implementing a colorectal cancer
screening program based on FOBT and colonoscopy for
cases with positive stools; perceived obstacles to client
participation; reasons, from a professional standpoint,
for reluctance to encourage clients to participate; bar-
riers against enlisting the collaboration of PHC profes-
sionals and, finally, viewpoints on what to offer
professionals to ensure their support to the program.
For the knowledge variables and some of the attitudinal
variables, the responses given were as follows: “Ia g r e e ”,
“I disagree” and “I don’t know”. On the specific question
of whether or not they would support a program of this
type, the possible responses were: “Yes, enthusiastically”,
“Yes, with some reluctance”, “No, absolutely not” and
“Id o n ’tk n o w ”. Regarding barriers and opportunities,
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in previous studies. For each of the options, the profes-
sional could choose “Yes”, “No” or “I don’t know”.
The study obtained the approval from the Primary
Health Care Research Committee, the Balearic Islands
Ethics Committee of Clinical Research and the IDIAP-
Jordi Gol Ethics Committee. Informed consent to PHC
professionals was not considered necessary.
Analysis
We introduced the questionnaires into a database in
Access using Teleform 4.0 for Windows.
In order to assess knowledge and attitudes held by
physicians and nurses with regard to colorectal cancer
screening, a descriptive analysis was performed. The
sample structure was not taken into account in the ana-
lysis. We determined the frequencies of the categorical
variables and assessed the normality of the continuous
variables, whose mean and median we calculated. We
carried out a bivariate analysis by type of professional
using all variables. We used the chi squared test to com-
pare hypotheses.
Secondly, to identify the factors related with the sup-
port afforded by PHC professionals to population
screening for colorectal cancer, we carried out a bivari-
a t ea n a l y s i s .F u r t h e r m o r e ,am u l t i v a r i a t el o g i s t i cr e g r e s -
sion analysis was performed using as dependent variable
support or lack of support to the screening programme.
Independent variables included were those showing a
statistical significance of p < 0.05 in bivariate analysis.
Backward logistic regression analysis was performed.
Independent variables were excluded from the model
when there was no statistical significative relationship
with the dependent variable and when the estimated
coefficients did not change markedly from the previous
model with the variable. In addition, each new model
was compared with the previous one through the likeli-
hood ratio.
As software we used SPSS 13.0 for Windows.
Results
We collected 1,219 questionnaires: 675 in the Balearic
Islands (response rate: 67,4%) and 544 in Barcelona
(95.6% of the anticipated sample). About 51.4% were phy-
sicians and 48.6% were nurses; 72.7% were women. The
median age of the professionals was 46 years (interquar-
tile range, IQR: 36-52). The median number of years
spent working in PHC was 14 (IQR: 6-20). About 48.9%
of the professionals were fixed staff, 28% were temporary
staff, 12.5% were substitutes, 2.1% were residents and in
8.5% of the cases work status was unknown. About 52%
worked in teaching health centres. The median number
of consultations a day was 35 (IQR: 30-40) for physicians
and 20 (IQR: 16-25) for nurses.
Interviewees’ knowledge and beliefs regarding colorec-
tal cancer, screening programs in general and colorectal
cancer screening in particular are presented in Table 1.
Professionals’ attitudes regarding population screening
for colorectal cancer based on testing FOBT and colo-
noscopy are presented in Table 2. It stands out that 68%
of all professionals would recommend this programme
to their clients and 31% are reluctant or do not know,
with no differences noted between physicians and
nurses. The majority (91.4% of nurses and 83.7% of phy-
sicians) of professionals were familiar with the proce-
dure for FOBT, although only 74.8% of nurses and
60.6% of physicians explained to their clients how to
perform the test.
About 84.5% of the PHC physicians and 14.3% of the
PHC nurses had recommended some type of screening
test for colorectal cancer to their clients during the pre-
vious year. When we asked them to specify which clients,
26% of professionals who had recommended some type of
screening test for colorectal cancer replied that it was
those with family antecedents of colorectal cancer, and
23% that it was those with suspicious clinical symptoms,
mainly anemia, rectal bleeding and changes in bowel habit.
The barriers perceived by PHC professionals with
respect to population screening for colorectal cancer are
shown in Table 3, together with their needs. Fear of
having to undergo a colonoscopy is what professionals
perceive to be the main obstacle to client participation.
Similarly, the invasive nature of colonoscopy is the main
reason for professionals’ reluctance. The primary bar-
riers in the way of professionals’ support the screening
program would be lack of knowledge for nurses and
lack of time for physicians. What professionals need the
most is training and information regarding the program.
In bivariate analysis, several factors were associated
with reluctance to support population screening for col-
orectal cancer, and they had to do with both knowledge
and attitudes. We noted no differences by type of pro-
fessional or area, an exception being the area in which
the pilot study is being conducted, where the percentage
of professionals who are reluctant to support a screen-
ing program for colorectal cancer is smaller than in the
rest of the study area.
In the multivariate analysis (Table 4), reluctant profes-
sionals were found to be those who believe the FOBT
has poor sensitivity and is difficult to perform; that colo-
noscopy is an invasive procedure; that not perceiving
any benefit from screening could deter their clients
from participating; that only a minority of their clients
would take part in such a program; and, finally, resis-
tance is felt by those who believe clients are fed up with
screening tests and those who don’t know if they should
be offered something to ensure their support to the
programme.
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professionals about colorectal cancer, cancer screening
programmes in general, and colorectal cancer screening
in particular
Questions Answers Total
(%)
Physicians
(%)
Nurses
(%)
Colorectal cancer is the most
common cancer in both sexes
together
I agree 58.5 69.0 47.1
I disagree 17.9 17.8 18.1
I don’t
know
23.6 13.2 34.8
Colorectal cancer is one of the
three leading causes of death
from cancer
I agree 77.6 87,5 66,9
I disagree 8.7 7.3 10.2
I don’t
know
13.7 5.2 22.9
About half of all people who
have colorectal cancer are still
alive 5 years after the diagnosis
I agree 69.6 80.1 58.3
I disagree 8.1 8.3 8.0
I don’t
know
22.3 11.6 33.7
The early diagnosis of
colorectal cancer, before the
onset of symptoms, is a
prognostic factor
I agree 90.5 95.4 85.0
I disagree 4.0 2.5 5.7
I don’t
know
5.5 2.1 9.3
The rapid diagnosis of
colorectal cancer, after the
onset of symptoms, is a
prognostic factor
I agree 80.9 84.3 76.0
I disagree 11.5 12.5 10.4
I don’t
know
7.6 3.2 12.8
The location of the colorectal
cancer (colon or rectum) is a
prognostic factor
I agree 70.2 71.0 69.3
I disagree 10.7 14.3 6.0
I don’t
know
19.1 14.8 24.6
Population screening
programmes target
asymptomatic subjects of
specific age groups
I agree 87.1 93.4 80.2
I disagree 5.0 3.7 6.3
I don’t
know
8.0 2.9 13.5
The purpose of a population
screening programme is to
reduce the mortality rate
I agree 85.4 86.9 83.7
I disagree 11.0 10.4 11.6
I don’t
know
3.7 2.8 4.7
Table 1 Knowledge and beliefs of primary care profes-
sionals about colorectal cancer, cancer screening pro-
grammes in general, and colorectal cancer screening in
particular (Continued)
A screening programme’s
effectiveness depends on the
% of the population that
participates in it
I agree 70.0 76.5 63.0
I disagree 14.4 13.2 15.7
I don’t
know
15.6 10.3 21.3
Prostate cancer screening by
testing for prostate-specific
antigen (PSA) is...
Effective 76.4 64.8 88.8
Ineffective 20.4 34.1 5.9
I don’t
know
3.2 1.1 5.3
Breast cancer screening by
means of mammography is...
Effective 98.3 99.2 97.4
Ineffective 0.6 0.5 0.7
I don’t
know
1.1 0.3 1.9
Lung cancer screening by
means of CAT scans is...
Effective 78 67.2 89.5
Ineffective 15.3 27.1 2.7
I don’t
know
6.7 5.7 7.7
Screening for colorectal cancer
by means of rectal
examination is...
Effective 60.1 57.3 63
Ineffective 30.1 39.5 20
I don’t
know
9.9 3.3 17
Screening for colorectal cancer
by testing for occult blood in
stools (FOBT) is...
Effective 83.9 83.1 84.7
Ineffective 11.3 15.1 7.1
I don’t
know
4.9 1.8 8.2
Screening for colorectal cancer
by means of colonoscopy is...
Effective 96.3 97.7 94.6
Ineffective 1.0 1.6 0.3
I don’t
know
2.8 0.6 5
The FOBT is too risky to be a
screening test
I agree 4.3 3.0 5.7
I disagree 83.3 92.4 72.7
I don’t
know
12.5 4.6 21.5
Colonoscopy is too risky to be
a screening test
I agree 33.4 36.6 29.8
I disagree 48.9 54.2 42.9
I don’t
know
17.6 9.2 27.4
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We have explored the knowledge and attitudes of PHC
professionals from two regions in Spain regarding popu-
lation screening for colorectal cancer. We have obtained
two kinds of responses: the ones associated to the pro-
fessionals themselves, and the ones derived from their
role as patient’s advocates, that is, their opinion about
how their patients would react towards a colorectal can-
cer screening programme. Patient’s attitudes will be
more thoroughly explored during the next phase of this
study in which general population will be surveyed and
interviewed.
In Spain, National Cancer Strategy [25] is promoting
the development of population screening programs for
colorectal cancer. Several regions are currently imple-
menting them. All but one are centralized programs, in
which PHC professionals play an insignificant role. The
Basque country program, the only one pivoted around
PHC professionals, is the one that until now has
obtained the highest rates of participation, around 59%
(data not published). In Cataluña, the pilot program for
population colorectal cancer screening has used the
guaiac FOBT test, obtaining low rates of participation in
the first rounds, 17.5% in the first round and 22.3% in
the second one [26]. Currently, the Cataluña Health
Department has decided to move to the immunological
FOBT test, used also in the other programs in Spain. In
Balearic Island, such decision has not yet taken. Instead,
the importance of pivoting the program around PHC
professionals is clear for the Balearic Health Depart-
ment, following the basque and the french models [27].
The strategy we followed yielded higher rates of PHC
worker participation than we had expected in light of
previous studies [16,28], which suggests that the subject
is of interest to these workers. However, a 23% of pro-
fessionals in Balearic Islands didn’t answer the question-
naire. This fact can have produced a selection bias,
since those who have not answered are probably the
most skeptical. Another noteworthy limitation of the
s t u d yi st h a tw em a yh a v ei n c u r r e di nw h a tm a yb e
referred to as “t h ep u b l i ch e a l t he x p e r t ’sb i a s ”,s i n c e
some of the questionnaire items were very technical and
particularly difficult for nursing staff. However, when we
designed the questionnaire we felt that anyone support-
ing a screening program has to be familiar with the
health problem targeted by the program, the features of
the test involved (sensitivity and specificity) and the pro-
gramme expected benefits.
Most PHC physicians and nurses believe that colorec-
tal cancer screening with FOBT is effective, although
more than half of the physicians and most nurses also
consider effective prostate cancer screening with pros-
tate-specific antigen (PSA) and lung cancer screening
with CAT scan. This casts doubt on their knowledge
regarding the available evidence on the effectiveness of
screening programs for different types of cancer. On the
other hand, when we asked them if they had recom-
mended some type of screening test for colorectal can-
cer to their clients over the previous year, most
physicians said yes. Nonetheless, when asked to specify
which clients, some professionals replied that it was
Table 2 Primary care professionals’ attitudes towards
population screening for colorectal cancer
Questions Answers Total
(%)
Physicians
(%)
Nurses
(%)
If a programme for
population
colorectal cancer
screening based on
FOBT and
colonoscopy were
implemented, would
you recomend it?
Yes, enthusiastically 68.5 69.2 67.8
Yes, with some
reluctance
23.7 23.5 23.9
I don’t know 7.4 6.8 8.0
No 0.4 0.5 0.3
How do you think
the clients in your
practice would react
to a programme for
population
screening for
colorectal cancer?
Almost everyone
would participate
27.8 30.8 24.7
About 50% would
participate
36.2 40.2 31.8
A minority would
participate
14.5 15.1 13.8
I don’t know 21.5 13.8 29.7
For users,
performing the
FOBT is...
Easy 41.8 37.3 46.6
Neither easy nor
hard
40.8 42.4 39.0
Complicated 14.2 16.9 11.2
I don’t know 3.3 3.4 3.3
What role do you
think you could play
in a colorectal
cancer screening
programme?*
General awareness-
raising among
clients about
colorectal cancer
and screening
92.2 90.8 93.6
Individual
counseling for
reluctant clients
91.5 93.4 89.4
Sending clients to
the programme if
they have not
received the letter
77.6 77.9 77.2
Capturing clients 74.3 74.1 74.5
Signing letters
inviting clients to
join the programme
45.7 49.7 41.1
* professionals who agree with each statement, versus those who disagree +
don’t know.
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cer, which leads us to suspect that they do not fully
understand what screening means. This is an important
issue because lack of knowledge about the concept of
population based screening programme was associated
in the multivariant analysis to reluctance to support it.
Around 70% of primary care workers would enthusias-
tically support a population screening program for col-
orectal cancer based on a FOBT and a colonoscopy for
cases with positive stools. This result is better than the
one obtained in other countries such as Australia (50%)
[24]. Another positive finding was that most profes-
sionals felt that their role in this type of program might
be to raise general awareness among clients and counsel
the ones showing reluctance. On the other hand, signing
letters of invitation to join the program, a strategy that
has effectively improved participation [29], was men-
tioned by less than half of all professionals, perhaps
because Spanish physicians and nurses, and especially
the former, dislike administrative tasks.
The main barriers expressed by PHC professsionals
for supporting a colorectal cancer screening program
were lack of knowledge among nurses and lack of time
among physicians. Both aspects emerged in a previous
qualitative study [21]. While improving the first factor is
feasible, changing the second one is difficult in the short
run. This, however, could be one more reason to leave
nurses in charge of raising general awareness among
users and counseling those harboring doubts, as the
physicians themselves have suggested [30], especially
since nurses appear to be more familiar than physicians
with the procedure of FOBT, a factor that could also
render them more willing to participate. In the United
States, on the other hand, nurses’ involvement in color-
ectal cancer screening is more geared towards perform-
ing sigmoidoscopies [31].
Health workers perceive the fear of having to undergo
a colonoscopy as the most important barrier to client
participation in a colorectal cancer screening program.
This parallels their own reluctance, since they consider
the procedure invasive and too hazardous for a screen-
ing test. The results of pilot studies carried out in Spain
have shown that colonoscopy is acceptable to a high
percentage − around 89% − of those who test positive
for FOBT [26]. Despite this, health professionals and cli-
ents should be fully aware of the risks and complications
of colonoscopy before subscribing to a program [32],
and they should also be aware of its benefits, since this
may encourage participation among professionals and,
through their influence, among clients as well [33].
Besides from the invasive feature of colonoscopy, poor
sensitivity and complicated procedure of FOBT were
associated to reluctance to support a colorectal cancer
screening program. FOBT poor sensitivity was also asso-
ciated to supporting a colorectal cancer screening pro-
gram in other studies [16,20], and also belief in FOBT
test efficacy [24]. Clearly, immunological test improve
guaiac test in both aspects [34]. Other factors associated
Table 3 Barriers and needs surrounding population
screening for colorectal cancer as perceived by primary
care professionals*
Questions Total
(%)
Physicians
(%)
Nurses
(%)
¿What obstacles do you think we would
encounter in trying to get your clients to
participate?
Fear of having to undergo a colonoscopy 71.1 73.3 68.6
Lack of knowledge about colorectal cancer 66.7 59.3 74.4
Fear of having a colorectal cancer found 60.2 60.1 60.3
The complicated nature of the procedure 41.9 49.3 33.7
Dislike or repulsion at having to handle
stools
22.6 26.3 18.6
Perceiving no benefit 17.1 17.6 16.5
Lack of trust in the public health system 6.2 6.4 5.9
¿What would make you reluctant to
encourage your clients to participate?
Colonoscopy is an invasive procedure 60.9 56.4 65.8
The anxiety generated by false positive
results
45.9 43.5 48.6
The fact that clients are fed up with
screening tests
33.5 34.4 32.5
The false sense of security from false
negative results
29.5 35.8 22.6
¿What are the main barriers to getting
PHC professionals to support the screening
program?
Lack of time 88.9 93.6 83.9
Professional burnout 62.5 70.0 54.0
Difficulty in explaining this information to
him/her
34.2 38.3 29.7
Lack of knowledge about screening
programmes
33.9 26.3 42.2
Participation in other screening
programmes
26.3 23.0 29.9
Lack of knowledge about colorectal cancer 24.8 15.4 35.0
Being disinterested in the matter 18.3 16.4 20.3
¿What do you think professionals should
be offered to ensure their support?
Training on colorectal cancer and
screening
94.4 92.4 96.5
Detailed information about the
programme
93.7 92.8 94.8
More time with each patient during
patient visits
93.4 95.1 91.7
Regular feedback about the results 92.9 93.8 91.8
Collaboration in writing papers 74.1 76.6 71.4
Economic compensation 43.8 37.1 51.1
Nothing, since it is part of their work 22.0 23.0 20.9
*professionals who agree with each statement versus those who disagree +
don’t know.
Ramos et al. BMC Cancer 2010, 10:500
http://www.biomedcentral.com/1471-2407/10/500
Page 6 of 9with reluctance were related with PHC professional’s
believes about their patient’s participation and tiredness
with screening procedures. Both will be explored in
depth in the next phase of the study.
Conclusions
Two in every three PHC professionals would support a
population screening program for colorectal cancer
screening. Factors associated with reluctance to recom-
mend it were related with screening test characteristics
as sensitivity and complexity of FOBT and with invasive
feature of colonoscopy. Other factors were related with
patients’ believes. Training programs will be needed
before the population screening is launched, in order to
maximize health professional’s support.
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Table 4 Multivariate analysis of factors associated with
being reluctant to support a population screening
programme based on testing for occult blood in stools
and colonoscopy*
Variable Categories p OR 95%
CI
Population screening
programmes target
asymptomatic
subjects of specific age groups
I agree 0.041 1
I don’t know 0.043 2.11 1.02-
4.35
I disagree 0.092 1.69 0.91-
3.12
Test for occult blood in stools
(FOBT) has poor sensitivity
No 0.008 1
I don’t know 0.018 1.88 1.11-
3.17
Yes 0.004 1.71 1.18-
2.48
Test for occult blood in stools
(FOBT) has poor specificity
No 0.022 1
I don’t know 0.467 0.80 0.45-
1.44
Yes 0.055 1.48 0.99-
2.21
For users, performing the FOBT
is...
Easy 0.002 1
Neither easy nor
hard
0.009 1.62 1.12-
2.32
I don’t know 0.008 3.26 1.36-
7.84
Complicated 0.002 2.06 1.29-
3.28
How would people react to a
population screening
programme for colorectal
cancer?
Almost everyone
would
participate
0.000 1
About 50%
would
participate
0.000 2.58 1.61-
4.15
A minority
would
participate
0.000 5.64 3.27-
9.74
I don’t know 0.000 4.61 2.73-
7.78
What barriers to client
participation would we
encounter?
￿ Perceiving no benefit I disagree 0.001 1
I don’t know 0.002 1.99 1.28-
3.07
I agree 0.011 1.71 1.13-
2.58
What would make you reluctant
to enourage clients to
participate?
￿ Clients are fed up with
screening programmes
I disagree 0.000 1
Table 4 Multivariate analysis of factors associated with
being reluctant to support a population screening pro-
gramme based on testing for occult blood in stools and
colonoscopy* (Continued)
I don’t know 0.555 1.17 0.69-
1.99
I agree 0.000 2.25 1.59-
3.17
￿ Colonoscopy is an invasive
procedure
I disagree 0.051 1
I don’t know 0.781 1.13 0.47-
2.71
I agree 0.017 1.53 1.08-
2.18
¿What do you think professionals
should be offered to ensure
their support to the screening
program?
￿ Nothing, since it is part of
their work
I agree 0.113 1
I don’t know 0.041 1.56 1.01-
2.41
I disagree 0.344 1.30 0.75-
2.25
* Nagelkerke’sR
2: 0,257.
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